As of November 7, 2026, Alumis Inc. is a publicly traded company (Nasdaq: ALMS). The largest holder reporting an active stake on Schedule 13D is Foresite Capital Fund VI LP, at 14.5%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Deep Track Capital (5.98%), BlackRock (5.7%) (Schedule 13D, August 17, 2026).
Is this your company?
About to sign with, pay or invest in Alumis Inc.? See the free Snapshot first.
Free to see. No signup.
Is Alumis Inc. a real, registered company?
- Alumis Inc files with the SEC under CIK 1847367 (its SEC filings).
- Its shares are listed under the ticker ALMS on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in South San Francisco, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under ALUMIS INC. in our court records and SEC 8-K records (as of 2026-11-07).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Foresite Capital Fund VI LP (filed 2026-08-17).
Who are Alumis Inc.'s owners and officers?
Alumis Inc.: incorporated in Delaware; business address in South San Francisco, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-11-05).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2024-07-24)
- : Executive Officer (Form D, 2024-07-24)
- : Executive Officer (Form D, 2024-07-24)
- : Executive Officer (Form D, 2024-07-24)
- : Executive Officer (Form D, 2024-07-24)
- : Executive Officer (Form D, 2024-07-24)
- : Executive Officer (Form D, 2024-07-24)
- : Executive Officer (Form D, 2024-07-24)
- : Director (Form D, 2024-07-24)
- : Director (Form D, 2024-07-24)
- : Director (Form D, 2024-07-24)
- : Director (Form D, 2024-07-24)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-05 | Fmr LLC | 0% |
| Schedule 13D, 2026-08-17 | Foresite Capital Fund Vi LP | 14.5% |
| Schedule 13G, 2026-08-06 | Fmr LLC | 5.5% |
| Schedule 13G, 2026-07-27 | Blackrock, Inc. | 5.7% |
| Schedule 13D/A, 2026-07-02 | Ayurmaya Capital Management Company, LP | 12.3% |
| Schedule 13G, 2026-04-07 | Deep Track Capital, LP | 5.98% |
| Schedule 13D/A, 2026-04-03 | Foresite Capital Fund Vi LP | 12.7% |
| Schedule 13D/A, 2026-01-13 | Samsara Biocapital, L.P. | 5.4% |
| Schedule 13D/A, 2026-01-12 | Foresite Capital Fund Vi LP | 14.1% |
| Schedule 13D, 2025-11-24 | Samsara Biocapital, L.P. | 5.3% |
| Schedule 13D/A, 2025-11-17 | Samsara Biocapital, L.P. | 4.9% |
| Schedule 13G/A, 2025-11-17 | Venbio Global Strategic Fund Iv, L.P. | 4.8% |
Questions about who owns Alumis Inc.
Who owns Alumis Inc.?
On this page, 5 holders' latest ownership filings report 5% or more of Alumis Inc.: Foresite Capital Fund Vi LP (14.5%, Schedule 13D, filed 2026-08-17), Ayurmaya Capital Management Company, LP (12.3%, Schedule 13D/A, filed 2026-07-02), Deep Track Capital, LP (5.98%, Schedule 13G, filed 2026-04-07), Blackrock, Inc. (5.7%, Schedule 13G, filed 2026-07-27) and Samsara Biocapital, L.P. (5.4%, Schedule 13D/A, filed 2026-01-13).
Who are the largest shareholders of Alumis Inc.?
By the share each holder's latest filing reports, the largest holders of Alumis Inc. on this page are Foresite Capital Fund Vi LP (14.5%), Ayurmaya Capital Management Company, LP (12.3%) and Deep Track Capital, LP (5.98%).
When did Foresite Capital Fund Vi LP buy into Alumis Inc.?
The filings give report dates, not purchase dates. The earliest filing from Foresite Capital Fund Vi LP on this page is the Schedule 13D/A, filed 2026-01-12, reporting 14.1%; its latest, Schedule 13D filed 2026-08-17, reports 14.5%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Alumis Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Alumis Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Alumis Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Alumis Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 15,139,707 shares, held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-05-23).
- AyurMaya Capital Management Company, LP, a director and 10% owner: 15,139,707 shares, held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-05-23).
- , a director: 7,239,362 shares, 3,553 held directly and 7,235,809 indirectly (Form 4, 2026-09-09).
- , a director and 10% owner: 680,486 shares, held indirectly (the form names the holder only in its footnotes) (Form 4, 2026-04-03).
- Foresite Labs Management I, LLC, a 10% owner: 680,486 shares, held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-04-03).
Shares only: the company's cover page does not give one share count for a single class, so no percentage is worked out.
How much has Alumis Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-07-24 | $40M | $40M |
| Form D, 2024-03-11 | $129.50M | $259M |
Keep reading
More on Alumis Inc. and the records around it.
Alumis Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
Companies that share a holder
- Foresite Capital Fund VI LP also filed stake reports on 4 other companies: IRulya Therapeutics Inc. (Oct 2026), Latigo Biotherapeutics, Inc. (Aug 2026), Verastem, Inc. (May 2026)
- Samsara BioCapital, L.P. also filed stake reports on 14 other companies: PMV Pharmaceuticals, Inc. (Sep 2026), Eloxx Pharmaceuticals, Inc. (Aug 2026), RANI THERAPEUTICS HOLDINGS, INC. (May 2026)
- Deep Track Capital, LP also filed stake reports on 59 other companies: Alector, Inc. (Oct 2026), TCGX Acquisition Corp. II (Oct 2026), Frazier Life Sciences Acquisition Corp. II (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/alumis